Zimmer Biomet Holdings ZBH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 70%-1.0pp | 69.7%-1.8pp | 71.4%-0.3pp | 71.1%-0.7pp | 71.1%-0.8pp | |
| Operating margin | 14%-3.0pp | 13.3%-3.4pp | 16.6%+0.2pp | 16.1%-0.4pp | 17%+0.7pp | |
| Net margin | 9.1%-2.8pp | 8.6%-3.2pp | 10.1%-4.2pp | 10.5%-2.7pp | 11.9%-1.1pp | |
| Returns | ||||||
| Return on equity | 6.1%-1.2pp | 5.6%-1.6pp | 6.4%-2.3pp | 6.5%-1.4pp | 7.3%-0.5pp | |
| Return on invested capital | 6.2%-0.1pp | 5.7%-0.4pp | 5.6%-1.4pp | 5.7%-1.2pp | 6.3%-0.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.7×-0.7× | 2×+0.1× | 2.4×+1.1× | 1.9×+0.6× | 2.4×+0.8× | |
| Leverage | ||||||
| Debt-to-equity | 0.6×0.0× | 0.6×+0.1× | 0.6×+0.1× | 0.6×+0.1× | 0.6×+0.1× | |
| Net debt / EBITDA | 3.1×+0.6× | 3.3×+0.7× | 2.8×+0.2× | 3×+0.6× | 2.5×0.0× | |
| Per Share | ||||||
| Book value per share | $64.73+4.3% | $63.90+4.5% | $64.17+5.3% | $63.16+2.3% | $62.07+1.6% | |
| Valuation | ||||||
| Market capitalization | $17.69B-21.5% | $17.82B-15.3% | $19.51B-12.1% | $18.27B-18.0% | $22.53B-18.2% | |
| Price / earnings | 23.2×-1.4× | 25.3×+2.0× | 24.2×+3.7× | 22.2×-0.1× | 24.7×-3.9× | |
| Price / sales | 2.1×-0.8× | 2.2×-0.6× | 2.4×-0.5× | 2.3×-0.6× | 2.9×-0.8× | |
| Price / book | 1.4×-0.4× | 1.4×-0.3× | 1.5×-0.3× | 1.5×-0.3× | 1.8×-0.4× | |
| EV / EBITDA | 10.8×-1.4× | 11.4×-0.4× | 10.9×-1.7× | 11×-1.6× | 12.2×-3.0× | |
| Dividend yield | 1.1%+0.2pp | 1.1%+0.1pp | 1%+0.1pp | 1.1%+0.2pp | 0.9%+0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Zimmer Biomet Holdings's profit margins?
- Zimmer Biomet Holdings (ZBH) runs a 70.0% gross margin and a 14.0% operating margin, with a 9.1% net margin.
- Where do Zimmer Biomet Holdings's ratios come from?
- Every ratio is computed from Zimmer Biomet Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
